This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

THELMA Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Lee Kyu

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	8.7yrs

Recent management updates

Recent updates

CEO

Lee Kyu

no data

Tenure

Lee Yil Kyu serves as the Chief Executive Officer at THELMA Therapeutics Co., Ltd. (formerly known as Medipartner Biotechnology. Co., Ltd.)

Board Members

Name	Position	Tenure	Compensation	Ownership
Park Hee	Executive Director	9.7yrs	no data	no data
Jong Park	Executive Director	9.7yrs	no data	no data
Jeong Seo	Executive Director	8.7yrs	no data	no data
Jae Oh	Executive Director	8.7yrs	no data	no data
Cho Ho Gyeon	Executive Director	8.7yrs	no data	no data
Jun Cho	Executive Director	8.1yrs	no data	no data
Ji Yoo	Non-Executive Director	8.7yrs	no data	no data
Yeon Cho	Non-Executive Director	9.7yrs	no data	no data

8.7yrs

Average Tenure

Experienced Board: A015540's board of directors are considered experienced (8.7 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/11/07 13:39
End of Day Share Price	2023/11/06 00:00
Earnings	2023/06/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

THELMA Therapeutics Co., Ltd. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution